7/26/2017 12:43:30 PM - Gapped down today violating its 50 DMA line, retreating from its all-time high. Fundamental concerns remain, however, as when noted with caution in the 7/29/15 mid-day report - "Quarterly and annual earnings history (C and A criteria) has been below guidelines of the fact-based investment system. Sales revenues increases have been sub par."
7/12/2017 12:28:46 PM - Consolidating within close striking distance of its 52-week and all-time highs. Found support near its 50 DMA line during its ongoing ascent this year. Fundamental concerns remain, however, as when last noted with caution in the 7/29/15 mid-day report - "Quarterly and annual earnings history (C and A criteria) has been below guidelines of the fact-based investment system. Sales revenues increases have been sub par."
7/29/2015 12:39:43 PM - Gapped up today hitting a new 52-week high. Quarterly and annual earnings history (C and A criteria) has been below guidelines of the fact-based investment system. Sales revenues increases have been sub par.
8/19/2008 1:10:31 PM - Recently challenging long-term chart resistance in the $94-95 area. Steady annual earnings history (good A criteria) and quarterly earnings increases have mostly been borderline with the +25% guideline. Sales revenues increases have been below the +25% guideline.
8/14/2008 12:54:30 PM - Recently challenging long-term chart resistance in the $94 area. Steady annual earnings history (good A criteria) and quarterly earnings increases have mostly been borderline with the +25% guideline. Sales revenues increases have been below the +25% guideline.
8/13/2008 12:51:20 PM - Steady annual earnings history (good A criteria) and quarterly earnings increases have mostly been borderline with the +25% guideline. Sales revenues increases have been below the +25% guideline.
5/15/2008 1:30:00 PM - Steady annual earnings and quarterly earnings increases have improved above the +25% guideline in the 2 most recent comparisons versus the year earlier results. Sales revenues increases have been below the +25% guideline.